Prostate Cancer Issues. Learn about the symptoms, detection and treatment of Prostate Cancer.
A Member of the Healthscout Network
 Printer Friendly  Send to a Friend

Obesity Tied to Prostate Cancer Recurrence

Leads to poor prognosis in both blacks and whites after surgery, study finds

FRIDAY, Aug. 21 (HealthDay News) -- Obesity increases the risk of prostate cancer recurrence in both black and white men, says a U.S. study that challenges previous research suggesting obesity may be more significant for black men.

"Not so. Obesity leads to worse cancer in both groups," study senior author Dr. Stephen Freedland, an associate professor of urology and pathology at the Duke University Medical Center Prostate Center, said in a news release from the school.

Advertisement
Related Stories
 border=
Vaccine Boosts Survival for Men With Advanced Prostate Cancer: Study
Most Men With Low-Risk Prostate Cancer Treated Aggressively, Study Shows
U.S. Cancer Death Rate Keeps Falling: Report
Related Videos
 border=
No More Biopsies?
Controlling Incontinence
Lycopene For Prostate Cancer
Related Slides
 border=
Prostate Cancer
Benign Prostate Hyperplasia


Freedland and study author Dr. Jayakrishnan Jayachandran, a urology oncology fellow, examined the medical records of 1,415 prostate cancer patients who had undergone a radical prostatectomy. They found that race had no influence on the relationship between obesity and the aggressiveness of the cancer.

"We found that higher BMI [body-mass index] was associated with significantly increased risk of cancer recurrence for both blacks and whites," Jayachandran said in the news release.

The reason why obesity increases the risk of prostate cancer recurrence isn't clear, but altered hormone levels might play a role.

"Obesity is associated with more estrogen and less testosterone, and it may be that lower testosterone promotes more aggressive tumors as recent studies have suggested," Jayachandran said.

Other obesity-related changes in the production of hormones, such as insulin, insulin-like growth factor or leptin, may also be involved in the development of more aggressive prostate cancer.

"This is something we simply do not understand, but we are actively studying all of these factors," Jayachandran said.

The study appears in the current issue of Cancer.

More information

The American Cancer Society has more about prostate cancer.

-- Robert Preidt

SOURCE: Duke University Medical Center, news release

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 8/21/2009



Disclaimer: The information provided on this website is for educational purposes only and does not serve as a replacement for care provided by your own personal health care team. This website does not render or provide medical advice, and no individual should make any medical decisions or change their health behavior based on information provided here. All pertinent content provided on this website should be discussed with your personal physician to evaluate whether it has any relevance to or impact on your specific condition. Reliance on any information provided by this website is solely at your own risk.


Jul 31, 2010
Home
Search
Powered By HealthLine
Patient Guide
News
Health Videos
Health Encyclopedia
Health News Archive
Affiliate Information
HealthScout Network
Contact Us
Newsletters
Privacy Policy
Terms of Use

We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service  

To find more information on specific conditions, please visit our partner sites: